Citraconic acid

CAS No. 498-23-7

Citraconic acid( Citraconic acid | Citraconsaeure | Kyselina citrakonova | Methylmaleic acid )

Catalog No. M18656 CAS No. 498-23-7

Citraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Citraconic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Citraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.
  • Description
    Citraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Citraconic acid | Citraconsaeure | Kyselina citrakonova | Methylmaleic acid
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Tyrosinase
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    498-23-7
  • Formula Weight
    130.1
  • Molecular Formula
    C5H6O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (768.64 mM)
  • SMILES
    C/C(=C/C(=O)O)/C(=O)O
  • Chemical Name
    2-methylfumaric acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • P505-15 Acetate

    P505-15 Acetate is a selective inhibitor of spleen tyrosine kinase that acts by suppressing leukocyte immune function and inflammation and leading to a reduction in arthritis score and attenuated histological damage.

  • ME0328

    ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about 7-fold selectivity over PARP1.

  • 5-Feruloylquinic aci...

    5-O-Feruloylquinic acid is a potent Sirt1 agonist, it is a potential lead compound that can be further tested in drug development process for diseases associated with aging.